Get the Stockscreener App
20.04
2.48%
-0.51
Korro Bio Inc stock is traded at $20.04, with a volume of 148.06K.
It is down -2.48% in the last 24 hours and up +41.23% over the past month.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
See More
Previous Close:
$20.55
Open:
$20.79
24h Volume:
148.06K
Relative Volume:
1.03
Market Cap:
$188.19M
Revenue:
-
Net Income/Loss:
$-81.17M
P/E Ratio:
-1.9774
EPS:
-10.1344
Net Cash Flow:
$-82.84M
1W Performance:
-1.09%
1M Performance:
+41.23%
6M Performance:
-23.77%
1Y Performance:
-54.65%
1-Day Range:
$19.65
$21.62
1-Week Range:
$18.52
$21.62
52-Week Range:
$10.29
$98.00
Korro Bio Inc Stock (KRRO) Company Profile
Name
Korro Bio Inc
Sector
Industry
Phone
617-468-1999
Address
60 FIRST STREET, CAMBRIDGE
Compare KRRO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
20.04 | 185.18M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-29-25 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-16-25 | Initiated | Chardan Capital Markets | Buy |
| Jan-10-25 | Initiated | Oppenheimer | Outperform |
| Oct-21-24 | Initiated | Raymond James | Strong Buy |
| Aug-14-24 | Initiated | William Blair | Outperform |
| Mar-28-24 | Reiterated | H.C. Wainwright | Buy |
| Feb-27-24 | Initiated | BMO Capital Markets | Outperform |
| Dec-04-23 | Initiated | H.C. Wainwright | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Nov-10-23 | Initiated | Piper Sandler | Overweight |
| Feb-15-23 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Feb-13-23 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-22-21 | Downgrade | Goldman | Buy → Neutral |
| Jan-27-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-22-20 | Initiated | B. Riley Securities | Buy |
| Jul-14-20 | Initiated | Oppenheimer | Outperform |
| May-18-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-28-19 | Initiated | Cowen | Outperform |
| Oct-28-19 | Initiated | Goldman | Buy |
| Oct-28-19 | Initiated | JP Morgan | Overweight |
View All
Korro Bio Inc Stock (KRRO) Latest News
Can Korro Bio Inc. Escape Recent Bear ChannelWatch List & AI Enhanced Trading Signals - newsyoung.net
Understanding Korro Bio Inc.’s price movementWeekly Profit Recap & Weekly Breakout Watchlists - Newser
Real time social sentiment graph for Korro Bio Inc.Market Activity Recap & Daily Volume Surge Signals - Newser
Published on: 2025-08-20 05:17:51 - Newser
Institutional scanner results for Korro Bio Inc.2025 Volume Leaders & Real-Time Volume Analysis - Newser
Can a trend reversal in Korro Bio Inc. lead to recoveryMarket Risk Report & Safe Entry Momentum Tips - Newser
Order flow analysis tools used on Korro Bio Inc.Weekly Earnings Recap & Real-Time Volume Trigger Notifications - Newser
Korro Bio Inc. stock trend outlook and recovery pathMarket Risk Summary & Safe Swing Trade Setup Alerts - Newser
Will Korro Bio Inc. see short term momentum2025 Technical Overview & Fast Entry High Yield Stock Tips - Newser
Building trade automation scripts for Korro Bio Inc.Risk Management & Daily Profit Focused Screening - Newser
Applying big data sentiment scoring on Korro Bio Inc.Buy Signal & Fast Gain Swing Alerts - Newser
Will Korro Bio Inc. bounce back from current supportAnalyst Upgrade & Safe Investment Capital Preservation Plans - Newser
Will Breakout in Korro Bio Inc. Sustain Through Next Week - mustnews.co.kr
Will Korro Bio Inc. continue its uptrend2025 Market Sentiment & Consistent Growth Equity Picks - Newser
Published on: 2025-08-19 15:08:52 - Newser
What institutions are buying Korro Bio Inc. stock nowRate Hike & Technical Confirmation Trade Alerts - Newser
Ranking Korro Bio Inc. among high performing stocks via toolsPortfolio Value Summary & AI Forecasted Entry and Exit Points - Newser
Is now a turning point for Korro Bio Inc.Portfolio Update Report & Daily Profit Focused Stock Screening - Newser
Published on: 2025-08-19 04:45:12 - Newser
Technical analysis overview for Korro Bio Inc. stockJuly 2025 Price Swings & Accurate Buy Signal Alerts - Newser
How Korro Bio Inc. stock performs during market volatilityQuarterly Trade Review & AI Enhanced Trading Signals - beatles.ru
FY2025 EPS Estimates for Korro Bio Reduced by Analyst - Defense World
How Resilient Is Korro Bio Inc. Stock During Economic Downturns2025 Analyst Calls & Weekly High Return Forecasts - Newser
Tick level data insight on Korro Bio Inc. volatility2025 Winners & Losers & Weekly Return Optimization Alerts - Newser
Using AI based signals to follow Korro Bio Inc.Weekly Trade Report & AI Powered Buy/Sell Recommendations - Newser
FY2025 EPS Estimates for Korro Bio Cut by Cantor Fitzgerald - Defense World
Korro Bio, Inc. (NASDAQ:KRRO) Receives Average Rating of “Buy” from Analysts - Defense World
How moving averages guide Korro Bio Inc. tradingTrade Performance Summary & Verified Momentum Stock Alerts - Newser
Korro Bio Inc. stock outlook for YEARWeekly Market Summary & Free Safe Entry Trade Signal Reports - Newser
Will earnings trigger a reversal in Korro Bio Inc.Wall Street Watch & Weekly Consistent Profit Watchlists - Newser
Q3 Earnings Forecast for Korro Bio Issued By HC Wainwright - Defense World
Korro Bio Inc Stock (KRRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Korro Bio Inc Stock (KRRO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):